Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Human papillomavirus (HPV)
2020
Americas
Europe
Clear all
Type of publications
NITAG documentation
(82)
Scientific publications
(1)
Systematic reviews (SYSVAC)
(3)
Topics
Available to download in languages
Regions
Americas
(65)
Europe
(21)
Africa
(2)
South-East Asia
(1)
Western Pacific
(20)
Countries
Belgium
(1)
Canada
(4)
Chile
(9)
Denmark
(1)
France
(5)
Netherlands
(1)
Sweden
(1)
United Kingdom
(11)
United States of America
(52)
Diseases
COVID-19
(79)
Human papillomavirus (HPV)
(8)
Diphtheria
(1)
Ebola
(3)
Hepatitis A
(1)
Influenza
(9)
Measles
(1)
Meningococcal disease
(1)
Pertussis
(1)
Pneumococcal disease
(3)
Tetanus
(1)
Tuberculosis
(1)
Typhoid
(1)
Varicella
(1)
Yellow fever
(1)
Vaccine topics
Acceptance
(2)
Coverage
(3)
Efficacy/effectiveness
(1)
Target population
Adolescents
(3)
Adults
(3)
Healthcare workers
(5)
Older adults
(2)
Parents/caregivers
(2)
Risk group
(3)
Publication date
2020
(86)
2024
(2)
2023
(27)
2022
(85)
2021
(145)
2019
(18)
2018
(18)
2017
(14)
2016
(18)
2015
(12)
2014
(17)
2013
(6)
2012
(2)
2011
(3)
2010
(7)
2009
(5)
2008
(2)
2007
(4)
86 results found
2020
∙
Ines Campos-Matos, Sema Mandal
Annex A: COVID-19 vaccine and health inequalities: considerations for prioritisation and implementation
2020
∙
William Gruber, ACIP
BNT162b2 Vaccine Candidate Against COVID-19
2020
∙
CAVEI
CAVEI interim recommendation for the initial prioritization of groups to be vaccinated against SARS-CoV-2 in the context of limited supply
2020
∙
CAVEI
CAVEI Interim statement on target groups for vaccination against SARS-COV-2
2020
∙
CAVEI
CAVEI ordinary meeting August 26th 2020
2020
∙
CAVEI
CAVEI ordinary meeting August 5th 2020
2020
∙
CAVEI
CAVEI ordinary meeting July 29th 2020
2020
∙
CAVEI
CAVEI ordinary meeting June 24th 2020
2020
∙
CAVEI
CAVEI provisional recommendation for the initial prioritization of groups to be vaccinated against SARS-CoV-2 in the context of limited supply
2020
∙
CAVEI
CAVEI recommendations to prioritize vaccination against SARS-COV-2 in health personnel during the campaign initiation phase and in the context of vaccine limited supply
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register